A Phase 1/3 Multicenter Trial Of Talimogene Laherparepvec In Combination With Pembrolizumab For Unresected, Stage Iiib-Iv Melanoma (Masterkey-265).
Reinhard Dummer,Antoni Ribas,Igor Puzanov,Olivier Michielin,Ari M. Vanderwalde,Robert Hans Ingemar Andtbacka,Jonathan Cebon,Eugenio Fernandez,Josep Malvehy,Anthony J. Olszanski,Thomas F. Gajewski,John M. Kirkwood,Olga Kuznetsova,Lisa Chen,Scott J. Diede,Jeffrey Chou,F. Stephen Hodi JOURNAL OF CLINICAL ONCOLOGY（2016）
AI 理解论文
溯源树
样例
